Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bellerophon Ther Com
(NQ:
BLPH
)
1.730
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
25
Open
1.730
Bid (Size)
1.730 (3)
Ask (Size)
1.880 (8)
Prev. Close
1.730
Today's Range
1.730 - 1.730
52wk Range
0.6700 - 3.500
Shares Outstanding
9,545,451
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
7 Micro-Cap Stocks to Buy for Risk-Taking Investors
January 27, 2023
These micro-cap stocks to buy have tremendous growth potential and a history of big moves, but they also come with plenty of volatility.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 18, 2023
Via
Benzinga
Performance
YTD
+92.22%
+92.22%
1 Month
-28.22%
-28.22%
3 Month
+50.80%
+50.80%
6 Month
+34.11%
+34.11%
1 Year
-25.75%
-25.75%
More News
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 11, 2023
Via
InvestorPlace
How Is The Market Feeling About Bellerophon Therapeutics?
January 06, 2023
Via
Benzinga
Bellerophon Therapeutics Shares Gained Over 200% Today
January 05, 2023
Via
Benzinga
Why Are Bellerophon Shares Jumping Today?
September 27, 2022
Via
Benzinga
Recap: Bellerophon Therapeutics Q1 Earnings
May 11, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 06, 2023
Via
Benzinga
Dow Falls Over 200 Points; Walgreens Earnings Top Expectations
January 05, 2023
Via
Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 05, 2023
Via
Benzinga
Nasdaq Down Over 100 Points; Crude Oil Rises 1%
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 21, 2022
Via
Benzinga
Nasdaq Turns Higher; Crude Oil Rises Over 2%
September 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Via
Benzinga
US Stocks Turn Lower; Dow Dips 175 Points
September 27, 2022
Via
Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
Via
Benzinga
Bellerophon Therapeutics: Q2 Earnings Insights
August 15, 2022
Via
Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
June 29, 2022
Via
Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
July 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 18, 2022
Via
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Via
Benzinga
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
June 27, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
May 17, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.